Daniel Billen Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity

AUPH Quotes by TradingView

Daniel Billen is Director of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 28,141 shares of AUPH, which is worth approximately $260,304. The most recent transaction as insider was on May 21, 2024, when has been sold 5,252 shares (Common Stock) at a price of $5.74 per share, resulting in proceeds of $30,146. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.1K
0% 3M change
15.73% 12M change
Total Value Held $260,304

Daniel Billen Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2024
SELL
Open market or private sale
$30,146 $5.74 p/Share
5,252 Reduced 15.73%
28,141 Common Stock
May 23 2023
SELL
Open market or private sale
$52,359 $11.26 p/Share
4,650 Reduced 12.22%
33,393 Common Stock
May 19 2023
BUY
Grant, award, or other acquisition
-
9,310 Added 19.66%
38,043 Common Stock
May 18 2023
BUY
Exercise of conversion of derivative security
-
8,733 Added 23.31%
28,733 Common Stock
DB

Daniel Billen

Director
Victoria, A1

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

News

Receive news related to Aurinia Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AUPH